Statins lower cholesterol, risk of death from heart disease, and now new research suggests they also reduce the risk of dying from cancer. But up to half of patients can’t get their cholesterol levels down far enough with the drugs, and researchers have had promising results with new monoclonal antibody injections that work with and without statins to drive levels down. The drugs, though, are still experimental.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help